@TOME V2.3
(Nov 2016)

Ref. - - Doc.
Global output mode :
Sort entries by :
Sequence Color type :

Show alignment :
Column output:
Score:

Alignment:

3D Common Core:

Structural Clustering:

Modeller Result :

Complexes Modeling
Templates Information:
Sequence & Result Tab:

Values color: [ Good | Correct | Middling | Bad ]Comparative Docking Tab: Displays ligands Score after transfer from template to model
Cell color: RMS between binding site of experimental template and receptor: [‹ 3Å | ‹ 10Å | › 10Å]
Result: [ Good | Correct | Acceptable | Bad | Empty = ligand not selected during the calculation step or result rejected ]

Query sequence : Rv3057c: (2016-05-16 )
MLQRGAGQYFAGKRCFVTGAASGIGRATALRLAAQGAELYLTDRDRDGLAQTVCDARALGAQVPEHRVLDVSDYQDVAAFAADIHARHPSMDVVLNIAGVSAWGTVDQLTHDQWSRMVAINLMGPIHVIETLVPPMVAAGRGGHLVNVSSAAGLVGLPWHAAYSASKYGLRGLSEVLRFDLARHGIGVSVVVPGAVKTPLVNTVEIAGVDRDDPRVNRWVERFSGHAVTPEKAADKILAGVTRNRYLVYTSADIRALYAFKRYAWWPYTLVMRRVNVFFTRALRPGP

Atome Classification :

(34 SA) Binding Score for complex ligand / Scwrl (Unconserved SChains Recalculated) model (Only selected ligand are displayed)
(Atome) (Ident) (Tito) (Num) (pKd) (Uniprot)

NAP_A_5(1X7G)
ACT3_STRCO
[Raw transfer]



NAP_E_5(1XR3)
ACT3_STRCO
[Raw transfer]



NDP_A_3(4DC1)
ACT3_STRCO
[Raw transfer]



NAI_B_5(4YAI)
?
[Raw transfer]



NAD_H_8(2D1Y)
?
[Raw transfer]



NAI_A_3(4YAG)
?
[Raw transfer]



NAD_A_5(4FN4)
?
[Raw transfer]



NAD_B_6(2PD6)
DHB8_HUMAN
[Raw transfer]



NAI_B_4(4YAG)
?
[Raw transfer]



NAI_A_3(4YAI)
?
[Raw transfer]



NAD_A_5(2PD6)
DHB8_HUMAN
[Raw transfer]



NAD_C_7(2PD6)
DHB8_HUMAN
[Raw transfer]



NAD_D_8(2PD6)
DHB8_HUMAN
[Raw transfer]



NAD_G_7(2D1Y)
?
[Raw transfer]



NAD_F_6(2D1Y)
?
[Raw transfer]



NAD_E_5(2D1Y)
?
[Raw transfer]



NAD_B_13(5HA5)
?
[Raw transfer]



NAD_D_25(5HA5)
?
[Raw transfer]



FMT_A_11(1W4Z)
ACT3_STRCO
[Raw transfer]



MPD_A_21(4H15)
?
[Raw transfer]
23 PsiBlast_CBE 75.5537%-105 - C1 -3PGX - Y4146_MYCPA -
24 PsiBlast_CBE 74.2137%-102 - C1 -3PGX - Y4146_MYCPA -
123 HHSearch 73.8029% -86 - C1 -3TSC - ? -
35 PsiBlast_CBE 72.9833% -94 - C1 -2RH4 - ACT3_STRCO -
1 PsiBlast_PDB 72.5438% -81 - C1 -4YAG 7.9 ?
103 PsiBlast_CBE 71.9533%-102 - C1 -2D1Y 9.5 ?
25 PsiBlast_CBE 71.5137%-101 - C1 -3PGX - Y4146_MYCPA -
3 PsiBlast_PDB 71.0437%-101 - C1 -3PGX - Y4146_MYCPA -
33 PsiBlast_CBE 70.9733% -99 - C1 -1W4Z - ACT3_STRCO -
36 PsiBlast_CBE 70.7733% -97 - C1 -4DC0 - ACT3_STRCO -
7 PsiBlast_PDB 70.7530% -95 - C1 -4Y9D - ? -
30 PsiBlast_CBE 70.3733% -97 - C1 -4DBZ - ACT3_STRCO -
2 PsiBlast_PDB 70.2038% -80 - C1 -4YAI 10.1 ?
29 PsiBlast_CBE 70.0533% -98 - C1 -4DC1 - ACT3_STRCO -
6 PsiBlast_PDB 69.8330% -93 - C1 -4Y98 - ? -
21 PsiBlast_CBE 69.4138% -83 - C1 -4YAI 9.3 ?
15 PsiBlast_PDB 69.3633% -95 - C1 -2RHC - ACT3_STRCO -
59 PsiBlast_CBE 68.9532% -87 - C1 -4CQM - DHB8_HUMAN -
32 PsiBlast_CBE 68.5333% -94 - C1 -1X7H - ACT3_STRCO -
66 PsiBlast_CBE 68.4932% -89 * C1 *4CQL - DHB8_HUMAN -
22 PsiBlast_CBE 68.3038% -80 - C1 -4YAG 9.9 ?
13 PsiBlast_PDB 67.7933% -96 - C1 -1W4Z 2.8 ACT3_STRCO
105 PsiBlast_CBE 67.4033%-103 - C1 -2D1Y 8.6 ?
49 PsiBlast_CBE 67.0832% -85 - C1 -2PD6 11.4 DHB8_HUMAN
104 PsiBlast_CBE 66.4933%-108 - C1 -2D1Y 9.1 ?
52 PsiBlast_CBE 66.1632% -87 - C1 -2PD6 11.5 DHB8_HUMAN
8 PsiBlast_PDB 66.1233% -94 - C1 -4DC1 12.7 ACT3_STRCO
102 PsiBlast_CBE 65.6033%-102 - C1 -2D1Y 9.3 ?
10 PsiBlast_PDB 65.6033% -93 - C1 -1X7G 8.4 ACT3_STRCO
12 PsiBlast_PDB 65.5233% -91 - C1 -1XR3 12.6 ACT3_STRCO
50 PsiBlast_CBE 65.2032% -84 - C1 -2PD6 11.6 DHB8_HUMAN
51 PsiBlast_CBE 64.5932% -84 - C1 -2PD6 11.5 DHB8_HUMAN
69 PsiBlast_CBE 53.3737% -90 - C1 -5HA5 8.2 ?
68 PsiBlast_CBE 52.3737% -85 - C1 -5HA5 8.3 ?